Baxter International is grappling with a substantial net income loss of $344 million and a drastic 35.5% decline in total returns over the past year, culminating in a current stock price of about $19.91. Following disappointing Q4 results and a bleak 2026 forecast, the company announced leadership shifts, including the appointment of Michael R. McDonnell to the board and the resignations of current board members. While analysts view Baxter's stock as undervalued, its recovery is hampered by ongoing margin compression and debt risks. The anticipated U.S. launch of the Dynamo Series smart stretcher and a $2.6 million grant for STEM programs may provide some buoyancy, but the company still faces significant financial headwinds.
“Baxter International · closed at · US$20.07”
“Baxter International (BAX) · has · 1-month return · 2.1%”
“Baxter International (BAX) · has · 3-month return · 10.9%”
“Baxter International (BAX) · has · 1-year total return decline · 35.5%”
“Baxter International (BAX) · last closed at · price · US$19.91”
“Baxter International (BAX) · carries · value score · 4”
“Baxter International (BAX) · reported annual revenue of · amount · US$11.0b”
“Baxter International (BAX) · reported net income loss of · amount · US$344.0m”
“Baxter International (BAX) · is considered · undervalued · 13.9%”
“Baxter International (BAX) · has a fair value estimate of · amount · $23.13”
“Baxter International (BAX) · is trading at · current price · $19.91”
“Baxter International (BAX) · has an intrinsic discount of · percentage · 4.3%”
